Stay updated on STX209 Effects in ASD Clinical Trial
Sign up to get notified when there's something new on the STX209 Effects in ASD Clinical Trial page.

Latest updates to the STX209 Effects in ASD Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference0.8%
- Check21 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check28 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.1%
- Check35 days agoChange DetectedThe web page has been updated to reflect a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with a revision update from v2.16.0 to v2.16.1.SummaryDifference1%
- Check64 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check78 days agoChange DetectedThe webpage has been updated to include new details about a study on STX209 for Autism Disorder, including the dosing regimen and collaborators, while removing extensive background information on the study's rationale and methodology.SummaryDifference24%
Stay in the know with updates to STX209 Effects in ASD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the STX209 Effects in ASD Clinical Trial page.